APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ofloxacin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ofloxacin Market Analysis and Forecast 2026-2032

20 December 2025191 pages

Choose your research edition.

Industry ResearchOfloxacin Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Ofloxacin Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Ofloxacin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ofloxacin Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Ofloxacin Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Ofloxacin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ofloxacin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ofloxacin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ofloxacin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ofloxacin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Ofloxacin include Janssen, Teva, Novartis, Daiichi Sankyo, Cadila Pharmaceuticals, Bestochem, Apotex, Almatica Pharma and Allergan, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ofloxacin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ofloxacin, also provides the sales of main regions and countries. Of the upcoming market potential for Ofloxacin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ofloxacin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ofloxacin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ofloxacin sales, projected growth trends, production technology, application and end-user industry.

Ofloxacin Segment by Company

Janssen

Teva

Novartis

Daiichi Sankyo

Cadila Pharmaceuticals

Bestochem

Apotex

Almatica Pharma

Allergan

Ofloxacin Segment by Type

Oral

Topical (Eye Drops & Ear Drops)

Intravenous Therapy (IV)

Ofloxacin Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Ofloxacin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ofloxacin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ofloxacin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ofloxacin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Ofloxacin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Ofloxacin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ofloxacin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ofloxacin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Major Manufacturers Table 3. Topical (Eye Drops & Ear Drops) Major Manufacturers Table 4. Intravenous Therapy (IV) Major Manufacturers Table 5. Global Ofloxacin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Pharmacies Major Manufacturers Table 7. Online Pharmacies Major Manufacturers Table 8. Retail Pharmacies Major Manufacturers Table 9. Ofloxacin Industry Trends Table 10. Ofloxacin Industry Drivers Table 11. Ofloxacin Industry Opportunities and Challenges Table 12. Ofloxacin Industry Restraints Table 13. Global Ofloxacin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Ofloxacin Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Ofloxacin Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Ofloxacin Revenue Market Share by Region (2021-2026) Table 17. Global Ofloxacin Revenue Market Share by Region (2027-2032) Table 18. Global Ofloxacin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kg) Table 19. Global Ofloxacin Sales by Region (2021-2026) & (kg) Table 20. Global Ofloxacin Sales by Region (2027-2032) & (kg) Table 21. Global Ofloxacin Sales Market Share by Region (2021-2026) Table 22. Global Ofloxacin Sales Market Share by Region (2027-2032) Table 23. Global Ofloxacin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Ofloxacin Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Ofloxacin Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Ofloxacin Sales Market Share by Manufacturers (2021-2026) Table 27. Global Ofloxacin Sales Price (US$/g) of Manufacturers (2021-2026) Table 28. Global Ofloxacin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Ofloxacin Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Ofloxacin Manufacturers, Product Type & Application Table 31. Global Ofloxacin Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Ofloxacin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Ofloxacin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Ofloxacin Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Ofloxacin Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Ofloxacin Revenue Market Share by Type (2021-2026) Table 38. Global Ofloxacin Revenue Market Share by Type (2027-2032) Table 39. Global Ofloxacin Sales by Type 2021 VS 2025 VS 2032 (kg) Table 40. Global Ofloxacin Sales by Type (2021-2026) & (kg) Table 41. Global Ofloxacin Sales by Type (2027-2032) & (kg) Table 42. Global Ofloxacin Sales Market Share by Type (2021-2026) Table 43. Global Ofloxacin Sales Market Share by Type (2027-2032) Table 44. Global Ofloxacin Price by Type (2021-2026) & (US$/g) Table 45. Global Ofloxacin Price by Type (2027-2032) & (US$/g) Table 46. Global Ofloxacin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Ofloxacin Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Ofloxacin Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Ofloxacin Revenue Market Share by Application (2021-2026) Table 50. Global Ofloxacin Revenue Market Share by Application (2027-2032) Table 51. Global Ofloxacin Sales by Application 2021 VS 2025 VS 2032 (kg) Table 52. Global Ofloxacin Sales by Application (2021-2026) & (kg) Table 53. Global Ofloxacin Sales by Application (2027-2032) & (kg) Table 54. Global Ofloxacin Sales Market Share by Application (2021-2026) Table 55. Global Ofloxacin Sales Market Share by Application (2027-2032) Table 56. Global Ofloxacin Price by Application (2021-2026) & (US$/g) Table 57. Global Ofloxacin Price by Application (2027-2032) & (US$/g) Table 58. Janssen Company Information Table 59. Janssen Business Overview Table 60. Janssen Ofloxacin Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 61. Janssen Ofloxacin Product Portfolio Table 62. Janssen Recent Development Table 63. Teva Company Information Table 64. Teva Business Overview Table 65. Teva Ofloxacin Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 66. Teva Ofloxacin Product Portfolio Table 67. Teva Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Ofloxacin Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 71. Novartis Ofloxacin Product Portfolio Table 72. Novartis Recent Development Table 73. Daiichi Sankyo Company Information Table 74. Daiichi Sankyo Business Overview Table 75. Daiichi Sankyo Ofloxacin Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 76. Daiichi Sankyo Ofloxacin Product Portfolio Table 77. Daiichi Sankyo Recent Development Table 78. Cadila Pharmaceuticals Company Information Table 79. Cadila Pharmaceuticals Business Overview Table 80. Cadila Pharmaceuticals Ofloxacin Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 81. Cadila Pharmaceuticals Ofloxacin Product Portfolio Table 82. Cadila Pharmaceuticals Recent Development Table 83. Bestochem Company Information Table 84. Bestochem Business Overview Table 85. Bestochem Ofloxacin Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 86. Bestochem Ofloxacin Product Portfolio Table 87. Bestochem Recent Development Table 88. Apotex Company Information Table 89. Apotex Business Overview Table 90. Apotex Ofloxacin Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 91. Apotex Ofloxacin Product Portfolio Table 92. Apotex Recent Development Table 93. Almatica Pharma Company Information Table 94. Almatica Pharma Business Overview Table 95. Almatica Pharma Ofloxacin Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 96. Almatica Pharma Ofloxacin Product Portfolio Table 97. Almatica Pharma Recent Development Table 98. Allergan Company Information Table 99. Allergan Business Overview Table 100. Allergan Ofloxacin Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 101. Allergan Ofloxacin Product Portfolio Table 102. Allergan Recent Development Table 103. North America Ofloxacin Revenue by Type (2021-2026) & (US$ Million) Table 104. North America Ofloxacin Revenue by Type (2027-2032) & (US$ Million) Table 105. North America Ofloxacin Sales by Type (2021-2026) & (kg) Table 106. North America Ofloxacin Sales by Type (2027-2032) & (kg) Table 107. North America Ofloxacin Sales Price by Type (2021-2026) & (US$/g) Table 108. North America Ofloxacin Sales Price by Type (2027-2032) & (US$/g) Table 109. North America Ofloxacin Revenue by Application (2021-2026) & (US$ Million) Table 110. North America Ofloxacin Revenue by Application (2027-2032) & (US$ Million) Table 111. North America Ofloxacin Sales by Application (2021-2026) & (kg) Table 112. North America Ofloxacin Sales by Application (2027-2032) & (kg) Table 113. North America Ofloxacin Sales Price by Application (2021-2026) & (US$/g) Table 114. North America Ofloxacin Sales Price by Application (2027-2032) & (US$/g) Table 115. North America Ofloxacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Ofloxacin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 117. North America Ofloxacin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 118. North America Ofloxacin Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 119. North America Ofloxacin Sales by Country (2021-2026) & (kg) Table 120. North America Ofloxacin Sales by Country (2027-2032) & (kg) Table 121. North America Ofloxacin Sales Price by Country (2021-2026) & (US$/g) Table 122. North America Ofloxacin Sales Price by Country (2027-2032) & (US$/g) Table 123. United States Ofloxacin Revenue (2021-2032) & (US$ Million) Table 124. Canada Ofloxacin Revenue (2021-2032) & (US$ Million) Table 125. Mexico Ofloxacin Revenue (2021-2032) & (US$ Million) Table 126. Europe Ofloxacin Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Ofloxacin Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Ofloxacin Sales by Type (2021-2026) & (kg) Table 129. Europe Ofloxacin Sales by Type (2027-2032) & (kg) Table 130. Europe Ofloxacin Sales Price by Type (2021-2026) & (US$/g) Table 131. Europe Ofloxacin Sales Price by Type (2027-2032) & (US$/g) Table 132. Europe Ofloxacin Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Ofloxacin Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Ofloxacin Sales by Application (2021-2026) & (kg) Table 135. Europe Ofloxacin Sales by Application (2027-2032) & (kg) Table 136. Europe Ofloxacin Sales Price by Application (2021-2026) & (US$/g) Table 137. Europe Ofloxacin Sales Price by Application (2027-2032) & (US$/g) Table 138. Europe Ofloxacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Ofloxacin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Europe Ofloxacin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Europe Ofloxacin Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 142. Europe Ofloxacin Sales by Country (2021-2026) & (kg) Table 143. Europe Ofloxacin Sales by Country (2027-2032) & (kg) Table 144. Europe Ofloxacin Sales Price by Country (2021-2026) & (US$/g) Table 145. Europe Ofloxacin Sales Price by Country (2027-2032) & (US$/g) Table 146. Germany Ofloxacin Revenue (2021-2032) & (US$ Million) Table 147. France Ofloxacin Revenue (2021-2032) & (US$ Million) Table 148. U.K. Ofloxacin Revenue (2021-2032) & (US$ Million) Table 149. Italy Ofloxacin Revenue (2021-2032) & (US$ Million) Table 150. Russia Ofloxacin Revenue (2021-2032) & (US$ Million) Table 151. Spain Ofloxacin Revenue (2021-2032) & (US$ Million) Table 152. Netherlands Ofloxacin Revenue (2021-2032) & (US$ Million) Table 153. Switzerland Ofloxacin Revenue (2021-2032) & (US$ Million) Table 154. Sweden Ofloxacin Revenue (2021-2032) & (US$ Million) Table 155. Poland Ofloxacin Revenue (2021-2032) & (US$ Million) Table 156. China Ofloxacin Revenue by Type (2021-2026) & (US$ Million) Table 157. China Ofloxacin Revenue by Type (2027-2032) & (US$ Million) Table 158. China Ofloxacin Sales by Type (2021-2026) & (kg) Table 159. China Ofloxacin Sales by Type (2027-2032) & (kg) Table 160. China Ofloxacin Sales Price by Type (2021-2026) & (US$/g) Table 161. China Ofloxacin Sales Price by Type (2027-2032) & (US$/g) Table 162. China Ofloxacin Revenue by Application (2021-2026) & (US$ Million) Table 163. China Ofloxacin Revenue by Application (2027-2032) & (US$ Million) Table 164. China Ofloxacin Sales by Application (2021-2026) & (kg) Table 165. China Ofloxacin Sales by Application (2027-2032) & (kg) Table 166. China Ofloxacin Sales Price by Application (2021-2026) & (US$/g) Table 167. China Ofloxacin Sales Price by Application (2027-2032) & (US$/g) Table 168. Asia Ofloxacin Revenue by Type (2021-2026) & (US$ Million) Table 169. Asia Ofloxacin Revenue by Type (2027-2032) & (US$ Million) Table 170. Asia Ofloxacin Sales by Type (2021-2026) & (kg) Table 171. Asia Ofloxacin Sales by Type (2027-2032) & (kg) Table 172. Asia Ofloxacin Sales Price by Type (2021-2026) & (US$/g) Table 173. Asia Ofloxacin Sales Price by Type (2027-2032) & (US$/g) Table 174. Asia Ofloxacin Revenue by Application (2021-2026) & (US$ Million) Table 175. Asia Ofloxacin Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia Ofloxacin Sales by Application (2021-2026) & (kg) Table 177. Asia Ofloxacin Sales by Application (2027-2032) & (kg) Table 178. Asia Ofloxacin Sales Price by Application (2021-2026) & (US$/g) Table 179. Asia Ofloxacin Sales Price by Application (2027-2032) & (US$/g) Table 180. Asia Ofloxacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia Ofloxacin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Asia Ofloxacin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Asia Ofloxacin Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 184. Asia Ofloxacin Sales by Country (2021-2026) & (kg) Table 185. Asia Ofloxacin Sales by Country (2027-2032) & (kg) Table 186. Asia Ofloxacin Sales Price by Country (2021-2026) & (US$/g) Table 187. Asia Ofloxacin Sales Price by Country (2027-2032) & (US$/g) Table 188. Japan Ofloxacin Revenue (2021-2032) & (US$ Million) Table 189. South Korea Ofloxacin Revenue (2021-2032) & (US$ Million) Table 190. India Ofloxacin Revenue (2021-2032) & (US$ Million) Table 191. Australia Ofloxacin Revenue (2021-2032) & (US$ Million) Table 192. Taiwan Ofloxacin Revenue (2021-2032) & (US$ Million) Table 193. Southeast Asia Ofloxacin Revenue (2021-2032) & (US$ Million) Table 194. SAMEA Ofloxacin Revenue by Type (2021-2026) & (US$ Million) Table 195. SAMEA Ofloxacin Revenue by Type (2027-2032) & (US$ Million) Table 196. SAMEA Ofloxacin Sales by Type (2021-2026) & (kg) Table 197. SAMEA Ofloxacin Sales by Type (2027-2032) & (kg) Table 198. SAMEA Ofloxacin Sales Price by Type (2021-2026) & (US$/g) Table 199. SAMEA Ofloxacin Sales Price by Type (2027-2032) & (US$/g) Table 200. SAMEA Ofloxacin Revenue by Application (2021-2026) & (US$ Million) Table 201. SAMEA Ofloxacin Revenue by Application (2027-2032) & (US$ Million) Table 202. SAMEA Ofloxacin Sales by Application (2021-2026) & (kg) Table 203. SAMEA Ofloxacin Sales by Application (2027-2032) & (kg) Table 204. SAMEA Ofloxacin Sales Price by Application (2021-2026) & (US$/g) Table 205. SAMEA Ofloxacin Sales Price by Application (2027-2032) & (US$/g) Table 206. SAMEA Ofloxacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. SAMEA Ofloxacin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. SAMEA Ofloxacin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. SAMEA Ofloxacin Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 210. SAMEA Ofloxacin Sales by Country (2021-2026) & (kg) Table 211. SAMEA Ofloxacin Sales by Country (2027-2032) & (kg) Table 212. SAMEA Ofloxacin Sales Price by Country (2021-2026) & (US$/g) Table 213. SAMEA Ofloxacin Sales Price by Country (2027-2032) & (US$/g) Table 214. Brazil Ofloxacin Revenue (2021-2032) & (US$ Million) Table 215. Argentina Ofloxacin Revenue (2021-2032) & (US$ Million) Table 216. Chile Ofloxacin Revenue (2021-2032) & (US$ Million) Table 217. Colombia Ofloxacin Revenue (2021-2032) & (US$ Million) Table 218. Peru Ofloxacin Revenue (2021-2032) & (US$ Million) Table 219. Saudi Arabia Ofloxacin Revenue (2021-2032) & (US$ Million) Table 220. Israel Ofloxacin Revenue (2021-2032) & (US$ Million) Table 221. UAE Ofloxacin Revenue (2021-2032) & (US$ Million) Table 222. Turkey Ofloxacin Revenue (2021-2032) & (US$ Million) Table 223. Iran Ofloxacin Revenue (2021-2032) & (US$ Million) Table 224. Egypt Ofloxacin Revenue (2021-2032) & (US$ Million) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. Ofloxacin Distributors List Table 228. Ofloxacin Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. Ofloxacin Image Figure 2. Global Ofloxacin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ofloxacin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Image Figure 5. Topical (Eye Drops & Ear Drops) Image Figure 6. Intravenous Therapy (IV) Image Figure 7. Global Ofloxacin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Ofloxacin Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Pharmacies Image Figure 10. Online Pharmacies Image Figure 11. Retail Pharmacies Image Figure 12. Global Ofloxacin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Ofloxacin Revenue (2021-2032) & (US$ Million) Figure 14. Global Ofloxacin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Ofloxacin Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Ofloxacin Revenue Market Share by Region (2021-2032) Figure 17. Global Ofloxacin Sales (2021-2032) & (kg) Figure 18. Global Ofloxacin Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 19. Global Ofloxacin Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Ofloxacin Sales YoY (2021-2032) & (kg) Figure 21. Europe Ofloxacin Sales YoY (2021-2032) & (kg) Figure 22. China Ofloxacin Sales YoY (2021-2032) & (kg) Figure 23. Asia (Excluding China) Ofloxacin Sales YoY (2021-2032) & (kg) Figure 24. South America, Middle East and Africa Ofloxacin Sales YoY (2021-2032) & (kg) Figure 25. Global Ofloxacin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Ofloxacin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Ofloxacin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Ofloxacin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Ofloxacin Revenue Market Share by Type (2021-2032) Figure 31. Global Ofloxacin Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 32. Global Ofloxacin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Ofloxacin Sales Market Share by Type (2021-2032) Figure 34. Global Ofloxacin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Ofloxacin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Ofloxacin Revenue Market Share by Application (2021-2032) Figure 37. Global Ofloxacin Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 38. Global Ofloxacin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Ofloxacin Sales Market Share by Application (2021-2032) Figure 40. North America Ofloxacin Revenue Share by Type (2021-2032) Figure 41. North America Ofloxacin Sales Share by Type (2021-2032) Figure 42. North America Ofloxacin Revenue Share by Application (2021-2032) Figure 43. North America Ofloxacin Sales Share by Application (2021-2032) Figure 44. North America Ofloxacin Revenue Share by Country (2021-2032) Figure 45. North America Ofloxacin Sales Share by Country (2021-2032) Figure 46. Europe Ofloxacin Revenue Share by Type (2021-2032) Figure 47. Europe Ofloxacin Sales Share by Type (2021-2032) Figure 48. Europe Ofloxacin Revenue Share by Application (2021-2032) Figure 49. Europe Ofloxacin Sales Share by Application (2021-2032) Figure 50. Europe Ofloxacin Revenue Share by Country (2021-2032) Figure 51. Europe Ofloxacin Sales Share by Country (2021-2032) Figure 52. China Ofloxacin Revenue Share by Type (2021-2032) Figure 53. China Ofloxacin Sales Share by Type (2021-2032) Figure 54. China Ofloxacin Revenue Share by Application (2021-2032) Figure 55. China Ofloxacin Sales Share by Application (2021-2032) Figure 56. Asia Ofloxacin Revenue Share by Type (2021-2032) Figure 57. Asia Ofloxacin Sales Share by Type (2021-2032) Figure 58. Asia Ofloxacin Revenue Share by Application (2021-2032) Figure 59. Asia Ofloxacin Sales Share by Application (2021-2032) Figure 60. Asia Ofloxacin Revenue Share by Country (2021-2032) Figure 61. Asia Ofloxacin Sales Share by Country (2021-2032) Figure 62. SAMEA Ofloxacin Revenue Share by Type (2021-2032) Figure 63. SAMEA Ofloxacin Sales Share by Type (2021-2032) Figure 64. SAMEA Ofloxacin Revenue Share by Application (2021-2032) Figure 65. SAMEA Ofloxacin Sales Share by Application (2021-2032) Figure 66. SAMEA Ofloxacin Revenue Share by Country (2021-2032) Figure 67. SAMEA Ofloxacin Sales Share by Country (2021-2032) Figure 68. Ofloxacin Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Ofloxacin Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Topical (Eye Drops & Ear Drops)
  • Intravenous Therapy (IV)
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Janssen
  • Teva
  • Novartis
  • Daiichi Sankyo
  • Cadila Pharmaceuticals
  • Bestochem
  • Apotex
  • Almatica Pharma
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ofloxacin Market by Type
  3. 1.2.1 Global Ofloxacin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 Topical (Eye Drops & Ear Drops)
  6. 1.2.4 Intravenous Therapy (IV)
  7. 1.3 Ofloxacin Market by Application
  8. 1.3.1 Global Ofloxacin Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital Pharmacies
  10. 1.3.3 Online Pharmacies
  11. 1.3.4 Retail Pharmacies
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Ofloxacin Market Dynamics
  1. 2.1 Ofloxacin Industry Trends
  2. 2.2 Ofloxacin Industry Drivers
  3. 2.3 Ofloxacin Industry Opportunities and Challenges
  4. 2.4 Ofloxacin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Ofloxacin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Ofloxacin Revenue by Region
  3. 3.2.1 Global Ofloxacin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ofloxacin Revenue by Region (2021-2026)
  5. 3.2.3 Global Ofloxacin Revenue by Region (2027-2032)
  6. 3.2.4 Global Ofloxacin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Ofloxacin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Ofloxacin Sales by Region
  9. 3.4.1 Global Ofloxacin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Ofloxacin Sales by Region (2021-2026)
  11. 3.4.3 Global Ofloxacin Sales by Region (2027-2032)
  12. 3.4.4 Global Ofloxacin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Ofloxacin Revenue by Manufacturers
  2. 4.1.1 Global Ofloxacin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Ofloxacin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Ofloxacin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ofloxacin Sales by Manufacturers
  6. 4.2.1 Global Ofloxacin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Ofloxacin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Ofloxacin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Ofloxacin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Ofloxacin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Ofloxacin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Ofloxacin Manufacturers, Product Type & Application
  13. 4.7 Global Ofloxacin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Ofloxacin Market CR5 and HHI
  16. 4.8.2 2025 Ofloxacin Tier 1, Tier 2, and Tier 3
5 Ofloxacin Market by Type
  1. 5.1 Global Ofloxacin Revenue by Type
  2. 5.1.1 Global Ofloxacin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Ofloxacin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Ofloxacin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Ofloxacin Sales by Type
  6. 5.2.1 Global Ofloxacin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ofloxacin Sales by Type (2021-2032) & (kg)
  8. 5.2.3 Global Ofloxacin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Ofloxacin Price by Type
6 Ofloxacin Market by Application
  1. 6.1 Global Ofloxacin Revenue by Application
  2. 6.1.1 Global Ofloxacin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Ofloxacin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Ofloxacin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Ofloxacin Sales by Application
  6. 6.2.1 Global Ofloxacin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Ofloxacin Sales by Application (2021-2032) & (kg)
  8. 6.2.3 Global Ofloxacin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Ofloxacin Price by Application
7 Company Profiles
  1. 7.1 Janssen
  2. 7.1.1 Janssen Company Information
  3. 7.1.2 Janssen Business Overview
  4. 7.1.3 Janssen Ofloxacin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Janssen Ofloxacin Product Portfolio
  6. 7.1.5 Janssen Recent Developments
  7. 7.2 Teva
  8. 7.2.1 Teva Company Information
  9. 7.2.2 Teva Business Overview
  10. 7.2.3 Teva Ofloxacin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Teva Ofloxacin Product Portfolio
  12. 7.2.5 Teva Recent Developments
  13. 7.3 Novartis
  14. 7.3.1 Novartis Company Information
  15. 7.3.2 Novartis Business Overview
  16. 7.3.3 Novartis Ofloxacin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Novartis Ofloxacin Product Portfolio
  18. 7.3.5 Novartis Recent Developments
  19. 7.4 Daiichi Sankyo
  20. 7.4.1 Daiichi Sankyo Company Information
  21. 7.4.2 Daiichi Sankyo Business Overview
  22. 7.4.3 Daiichi Sankyo Ofloxacin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Daiichi Sankyo Ofloxacin Product Portfolio
  24. 7.4.5 Daiichi Sankyo Recent Developments
  25. 7.5 Cadila Pharmaceuticals
  26. 7.5.1 Cadila Pharmaceuticals Company Information
  27. 7.5.2 Cadila Pharmaceuticals Business Overview
  28. 7.5.3 Cadila Pharmaceuticals Ofloxacin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Cadila Pharmaceuticals Ofloxacin Product Portfolio
  30. 7.5.5 Cadila Pharmaceuticals Recent Developments
  31. 7.6 Bestochem
  32. 7.6.1 Bestochem Company Information
  33. 7.6.2 Bestochem Business Overview
  34. 7.6.3 Bestochem Ofloxacin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Bestochem Ofloxacin Product Portfolio
  36. 7.6.5 Bestochem Recent Developments
  37. 7.7 Apotex
  38. 7.7.1 Apotex Company Information
  39. 7.7.2 Apotex Business Overview
  40. 7.7.3 Apotex Ofloxacin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Apotex Ofloxacin Product Portfolio
  42. 7.7.5 Apotex Recent Developments
  43. 7.8 Almatica Pharma
  44. 7.8.1 Almatica Pharma Company Information
  45. 7.8.2 Almatica Pharma Business Overview
  46. 7.8.3 Almatica Pharma Ofloxacin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Almatica Pharma Ofloxacin Product Portfolio
  48. 7.8.5 Almatica Pharma Recent Developments
  49. 7.9 Allergan
  50. 7.9.1 Allergan Company Information
  51. 7.9.2 Allergan Business Overview
  52. 7.9.3 Allergan Ofloxacin Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Allergan Ofloxacin Product Portfolio
  54. 7.9.5 Allergan Recent Developments
8 North America
  1. 8.1 North America Ofloxacin Market Size by Type
  2. 8.1.1 North America Ofloxacin Revenue by Type (2021-2032)
  3. 8.1.2 North America Ofloxacin Sales by Type (2021-2032)
  4. 8.1.3 North America Ofloxacin Price by Type (2021-2032)
  5. 8.2 North America Ofloxacin Market Size by Application
  6. 8.2.1 North America Ofloxacin Revenue by Application (2021-2032)
  7. 8.2.2 North America Ofloxacin Sales by Application (2021-2032)
  8. 8.2.3 North America Ofloxacin Price by Application (2021-2032)
  9. 8.3 North America Ofloxacin Market Size by Country
  10. 8.3.1 North America Ofloxacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Ofloxacin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Ofloxacin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Ofloxacin Market Size by Type
  2. 9.1.1 Europe Ofloxacin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Ofloxacin Sales by Type (2021-2032)
  4. 9.1.3 Europe Ofloxacin Price by Type (2021-2032)
  5. 9.2 Europe Ofloxacin Market Size by Application
  6. 9.2.1 Europe Ofloxacin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Ofloxacin Sales by Application (2021-2032)
  8. 9.2.3 Europe Ofloxacin Price by Application (2021-2032)
  9. 9.3 Europe Ofloxacin Market Size by Country
  10. 9.3.1 Europe Ofloxacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Ofloxacin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Ofloxacin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Ofloxacin Market Size by Type
  2. 10.1.1 China Ofloxacin Revenue by Type (2021-2032)
  3. 10.1.2 China Ofloxacin Sales by Type (2021-2032)
  4. 10.1.3 China Ofloxacin Price by Type (2021-2032)
  5. 10.2 China Ofloxacin Market Size by Application
  6. 10.2.1 China Ofloxacin Revenue by Application (2021-2032)
  7. 10.2.2 China Ofloxacin Sales by Application (2021-2032)
  8. 10.2.3 China Ofloxacin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ofloxacin Market Size by Type
  2. 11.1.1 Asia Ofloxacin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Ofloxacin Sales by Type (2021-2032)
  4. 11.1.3 Asia Ofloxacin Price by Type (2021-2032)
  5. 11.2 Asia Ofloxacin Market Size by Application
  6. 11.2.1 Asia Ofloxacin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Ofloxacin Sales by Application (2021-2032)
  8. 11.2.3 Asia Ofloxacin Price by Application (2021-2032)
  9. 11.3 Asia Ofloxacin Market Size by Country
  10. 11.3.1 Asia Ofloxacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Ofloxacin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Ofloxacin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ofloxacin Market Size by Type
  2. 12.1.1 SAMEA Ofloxacin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Ofloxacin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Ofloxacin Price by Type (2021-2032)
  5. 12.2 SAMEA Ofloxacin Market Size by Application
  6. 12.2.1 SAMEA Ofloxacin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Ofloxacin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Ofloxacin Price by Application (2021-2032)
  9. 12.3 SAMEA Ofloxacin Market Size by Country
  10. 12.3.1 SAMEA Ofloxacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Ofloxacin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Ofloxacin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Ofloxacin Value Chain Analysis
  2. 13.1.1 Ofloxacin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Ofloxacin Production Mode & Process
  6. 13.2 Ofloxacin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Ofloxacin Distributors
  9. 13.2.3 Ofloxacin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst